Category: Medical Professional News
What is ADAM? – Patient Resource
Patient Resource – Website What is ADAM? ADAM stands for Androgen Deficiency in Ageing Men. Basically, it means that your male hormone level has… Continue Reading →
Australasian Menopause Society Congress: 9-11 September
AMS Congress 2022 The AMS is pleased to announce the 25th Annual Australasian Menopause Society Congress will be held at the Cairns Convention Centre… Continue Reading →
HealthEd Seminar: The Annual Women’s & Children’s Health Update 2022
Leading experts present their independent views and advice in 2022 Brisbane – 4 June | Sydney – 6 August | Perth – 27 August… Continue Reading →
Adelaide Event: Menopause Essentials Update – 4th June
Menopause Essentials Update ABOUT This update on Menopause is aimed at GP’s, gynaecologists, endocrinologists and other health professionals who are seeking a comprehensive review… Continue Reading →
What is HSDD? – Patient Resource
Patient Resource – Website What is HSDD? Hypoactive sexual desire dysfunction (HSDD) is an extremely common medical condition that causes distress resulting from a… Continue Reading →
IMS: Sexual wellbeing after menopause
Patient Support Material: Free yourself and embrace positive sexual wellbeing Sexual health is a state of physical, emotional, mental and social wellbeing related to… Continue Reading →
Share your opinions as a woman with POI/ Premature menopause.
International POI guideline update survey What matters for you? A 10 minute scoping survey for women or for health professionals: An international collaboration between the European… Continue Reading →
Jean Hailes: National Women’s Health Survey
National Women’s Health Survey Welcome to Jean Hailes survey This survey was developed by Jean Hailes for Women’s Health and a team of experts…. Continue Reading →
Monash University: Bone Density Study
A study to prevent bone loss and restore sexual function in women with primary ovarian insufficiency Melbourne and Perth As many as 4 in… Continue Reading →
AndroFeme 1 licensed for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals has obtained approval for registration of AndroFeme® 1 in the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →